Lenvatinib and Everolimus in Treating Patients With Advanced, Unresectable Carcinoid Tumors
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
Centre Oscar Lambret
Stanford University
University of California, San Francisco
M.D. Anderson Cancer Center
University of California, Davis
Memorial Sloan Kettering Cancer Center
Grupo Espanol de Tumores Neuroendocrinos
National Institute of Cardiology, Warsaw, Poland
Columbia University
Olivia Newton-John Cancer Research Institute
Cedars-Sinai Medical Center
University of Florida
Assistance Publique - Hôpitaux de Paris
University of Utah
University of Alberta
Institut du Cancer de Montpellier - Val d'Aurelle
Jonsson Comprehensive Cancer Center
Institut du Cancer de Montpellier - Val d'Aurelle
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Barbara Ann Karmanos Cancer Institute
University of Nebraska
University of Wisconsin, Madison
IRCCS San Raffaele
Imperial College London
Imperial College London
Imperial College London
Mayo Clinic
Rezolute
First Affiliated Hospital of Zhejiang University
University Hospital, Strasbourg, France
Shanghai Zhongshan Hospital
Ohio State University Comprehensive Cancer Center
University of Iowa
University of Miami
Washington University School of Medicine
Abramson Cancer Center at Penn Medicine
Nantes University Hospital
Rezolute
University Health Network, Toronto
Fox Chase Cancer Center
Hospices Civils de Lyon
Imperial College London
Hospices Civils de Lyon
University of Alberta
University of Iowa
University of Michigan Rogel Cancer Center
Lund University Hospital
University of California, San Francisco
Grupo Espanol de Tumores Neuroendocrinos